CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

VGM Playbook: Technology-Driven Strategies and Resources Now Available thumbnail VGM Playbook: Technology-Driven Strategies and Resources Now Available “VGM Playbook: Technology-Driven Strategies and Resources” is designed to help VGM members harness the power of technology and artificial intelligence (AI). Building a Better Tomorrow thumbnail Building a Better Tomorrow As the fall colors begin to paint the landscape, it's a time to reflect on what we've achieved and the challenges we've overcome in 2025. This year has brought transformation to the home accessibility industry while continuing to meet the growing needs of our aging population. However, the journey has not been without hurdles. O&P Legislation: A Bill Where All Parties Benefit thumbnail O&P Legislation: A Bill Where All Parties Benefit Recent fraud takedown will fuel support for O&P legislation, stakeholders say. Live at Home Sees Spike in Interest in Home Access Market thumbnail Live at Home Sees Spike in Interest in Home Access Market VGM Live at Home's Cindi Petito is noticing increased interest in the home accessibility market in the wake of CMS's decision to resurrect competitive bidding. Meet The 2025 O&P Woman of the Year, Fanny Schultea thumbnail Meet The 2025 O&P Woman of the Year, Fanny Schultea OPGA is proud to announce that Fanny Schultea, MS, MSEd, CPO, LP, FAAOP, Executive Director of The Orthotics and Prosthetics Foundation for Education and Research, has been selected as the 2025 O&P Woman of the Year. Setting Up Your HME for Enrollment Success thumbnail Setting Up Your HME for Enrollment Success Unlock enrollment success for your HME business with tips on provider enrollment, CMS compliance, and avoiding pitfalls. Stay prepared and compliant. September Shift: From Busy to Better—Owning the Home in HME thumbnail September Shift: From Busy to Better—Owning the Home in HME Discover how HME providers can shift from busy to better this September. Learn strategies for enhancing patient experiences, improving operational efficiency, and navigating payer complexities. Join us in building lasting customer relationships and fostering community engagement for a successful Q4 and beyond. The Role of DMEPOS in Value-Based Healthcare thumbnail The Role of DMEPOS in Value-Based Healthcare Explore how DMEPOS providers contribute to value-based care by enhancing patient outcomes, reducing costs, and promoting healthcare transformation.